您当前的位置：
首页 >
文章列表页 >
High altitude heart disease: current status, challenges, and future directions in clinical management
Medical Journal of Chinese People′s Liberation Army   Pages: 1-7(2025)
更新时间：2025-10-20

    • High altitude heart disease: current status, challenges, and future directions in clinical management

    • “In the field of high-altitude heart disease, experts have explored the potential value of new biological markers and imaging techniques in diagnosis, providing solutions for building a precise diagnostic system.”

    • DOI：10.11855/j.issn.0577-7402.1008.2025.1017    

      CLC： R595.6

    • Received：27 May 2025，

      Accepted：20 August 2025，

      Published Online：19 October 2025，

    移动端阅览

  • Liu Yu-Xiang,Zhang Yu-Xiao,Tian Ting-Ting,et al.High altitude heart disease: current status, challenges, and future directions in clinical management[J].Medical Journal of Chinese People′s Liberation Army, DOI：10.11855/j.issn.0577-7402.1008.2025.1017.

  •  
  •  

0

Views

0

下载量

0

CSCD

0

CNKI被引量

>
Alert me when the article has been cited
提交
Outline
No Sections

Related Articles

Therapeutic efficacy and its mechanism of methylprednisolone on smoke inhalation-induced acute lung injury in rats
Advances in research of pathophysiological mechanisms and diagnosis of Alzheimer's disease
Value of the new WHO pathological classification of pituitary tumors in diagnosis and treatment of clinically non-functioning pituitary adenomas
The research progress on the correlation between gut microbiota and Graves' ophthalmopathy

Related Author

Li Hu-Ming
Chen Xu-Xin
Li Yong-Qun
Zhang Chun-Yang
Zhang Yan
Chen Wei
Han Zhi-Hai
Wang Ya-Nan

Related Institution

Department of Pulmonary and Critical Care Medicine, the Sixth Medical Center of Chinese PLA General Hospital
College of Pulmonary and Critical Care Medicine, the Eighth Medical Center of Chinese PLA General Hospital
Department of Nuclear Medicine, Capital Medical University Electric Power Teaching Hospital/State Grid Beijing Electric Power Hospital
Shenzhen Runming Biotech Co. Ltd.
China Resources Pharmaceutical Commercial Medical Device Research Institute
0